Vinaigre de cidre pur 1000mg
Food supplement declared in France, declaration No 2024-1-320, decision dated 8 January 2024
Vinaigre de cidre pur 1000mg (Malebiau) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Vinaigre de cidre. None of the rules we check flags an issue with its declared composition.
- Brand
- Malebiau
- Food business operator placing the product on the market
- Laboratoire Nature AZ
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 4 gélules
- Directions for use
- Prendre 4 gélules le matin au moment du repas avec un grand verre d’eau.
- Intended populations
- Men, Women
- Objectives stated by the manufacturer (these are not authorised claims)
- Antioxidant, Digestion, Slimming / Blood sugar, Slimming / Appetite control
Declaration 138036, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Other active ingredients
| Name | Per day |
|---|---|
| Vinaigre de cidre | not declared |
Other ingredients
Gélule végétale
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Brand : Malebiau
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Vinaigre de cidre pur 1000mg (Malebiau): composition and regulation”, https://compoatlas.com/en/supplements/products/138036-vinaigre-de-cidre-pur-1000mg, updated 15 November 2026.